The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus
- Authors: Volkov S.N.1, Mikheev R.K.1, Grigoryan O.R.1, Andreeva E.N.1,2
-
Affiliations:
- FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health (the director – the corresponding member of RAS Mokrysheva N.G.)
- Department of the Reproductive Medicine and Surgery (Head – the academician of RAS Adamyan L.V.), of the A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Issue: No 4 (2023)
- Pages: 40-45
- Section: ORIGINAL ARTICLES
- URL: https://bakhtiniada.ru/1728-2985/article/view/275367
- DOI: https://doi.org/10.18565/urology.2023.4.40-45
- ID: 275367
Cite item
Open Access
Access granted
Subscription Access
Abstract
Aim. To compare the efficiency of two surgical methods, holmium laser enucleation of prostate (HoLEP) and laparoscopic retropubic simple prostatectomy with clamping of internal iliac arteries and vesicourethral anastomosis [LPA+CIIA+VUA]) for treating of patients with benign prostatic hyperplasia (BPH) and type 2 diabetes mellitus (T2DM).
Materials and methods. A total of 56 men with T2DM who underwent surgical treatment of BPH in the National Research Centre for Endocrinology of the Russian Ministry of Health (director – corresponding member of RAS Mokrysheva N.G..) in a period from 2021 until 2022 were included in the study. Patients with T2DM received two types of antidiabetic drugs: basal-bolus insulin therapy and metformin (1000 mg/day per os). Patients were divided into the group of LPA+CIIA+VUA (n=28) and HoLEP (n=28). Preoperative, intraoperative and postoperative examinations with an evaluation of intraoperative and early postoperative complications (I, II, III, IV grades according to the Clavien-Dindo scale) were performed. After 1 year of follow-up, International Prostatic Symptom Score (IPSS), “Quality of Life” score (QoL), International Index of Erectile Function-5 score (IIEF-5), maximal urine flow rate (Qmax), and postvoid residual volume (ml) were assessed. Efficiency of surgical procedures was estimated according to “trifecta”: absence of postoperative complications, urine continence, maximal urine flow (Qmax) >15 ml/sec.
Results. In the group of HoLEP, shorter postoperative bladder catheterization time but higher risk of urinary incontinence, bladder neck contracture and urethral strictures was found. LPA+CIIA+UVA leaded to a two-fold decrease in intraoperative hemoglobin loss with no necessity of repeat procedures.
Conclusions. Our preliminary results demonstrated higher efficacy of LPA+CIIA+VUA for treatment of BPH in patients with T2DM than HoLEP. Patients who underwent LPA+CIIA+VUA were more often achieved the “trifecta”. In order to implement LPA+CIIA+VUA into clinical practice, multi-center, large-scale, double-blind, placebo-controlled (“scar-surgery”) randomized studies are required.
Full Text
##article.viewOnOriginalSite##About the authors
S. N. Volkov
FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health (the director – the corresponding member of RAS Mokrysheva N.G.)
Email: volkov_stas08@mail.ru
Ph.D., the leader of the Department of Urology and Andrology of the FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health
Russian Federation, MoscowR. K. Mikheev
FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health (the director – the corresponding member of RAS Mokrysheva N.G.)
Author for correspondence.
Email: iceberg1995@mail.ru
resident at the FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health
Russian Federation, MoscowO. R. Grigoryan
FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health (the director – the corresponding member of RAS Mokrysheva N.G.)
Email: iceberg1995@mail.ru
Ph.D., MD, professor, chief researcher of the Department of Endocrine gynecology of FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health
Russian Federation, MoscowE. N. Andreeva
FSBE National Medicine Research Centre for Endocrinology of the Russian Ministry of Health (the director – the corresponding member of RAS Mokrysheva N.G.); Department of the Reproductive Medicine and Surgery (Head – the academician of RAS Adamyan L.V.), of the A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: endogin@mail.ru
Ph.D., MD, Director of the Institute of the Reproductive medicine of FSBE National Medicine Research Centre for Endocrinology, Head of the Department of Endocrine gynecology of FSBE National Medicine Research Centre for Endocrinology, professor of the Department of the Reproductive Medicine and Surgery of the A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation, Moscow; MoscowReferences
- Lerner L.B., McVary K.T., Barry M.J., Bixler B.R., Dahm P., Das A.K., Gandhi M.C., Kaplan S.А., Kohler T.S., Martin L., Parsons J.K., Roehrborn C.G., Stoffel J.T., Welliver C., Wilt T.J. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021;206(4):806–817. doi: 10.1097/JU.0000000000002183. Epub 2021 Aug 13. Erratum in: J Urol. 2021 Nov;206(5):1339. PMID: 34384237.
- Ng M., Baradhi K.M. Benign Prostatic Hyperplasia. 2022 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. PMID: 32644346.
- Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.А. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204–221. https://doi.org/10.14341/DM12759 Russian. (Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А. Эпидемиологические характеристики сахарного диабета в Российской Федерации: клинико-статистический анализ по данным регистра сахарного диабета на 01.01.2021. Сахарный диабет. 2021; 24(3):204-221).
- Opara N.U. Diabetes mellitus-induced lower urinary tract symptoms and hepatic steatosis in an older male. Endocrinol Diabetes Metab Case Rep. 2022;2022:22–0290. doi: 10.1530/EDM-22-0290. Epub ahead of print. PMID: 36125050; PMCID: PMC9513662.
- Vartolomei L, Cotruș A, Tătaru SO, Vartolomei MD, Man A, Ferro M, Stanciu C., Sin A.I., Shariat S.F. Lower urinary tract symptoms are associated with clinically relevant depression, anxiety, and stress symptoms. Aging Male. 2022;25(1):62–66. doi: 10.1080/13685538.2022.2040981. PMID: 35179090
- Summner W A. Transurethral resection; a history and a heritage. Trans West Sect Am Urol Assoc. 1956;23:99–103. PMID: 13401471
- Das A.K., Teplitsky S., Humphreys M.R. Holmium laser enucleation of the prostate (HoLEP): a review and update. Can J Urol. 2019;26(4 Suppl 1):13–19. PMID: 31481144.
- Becker B,. Enikeev D,. Netsch C., Gross A.J., Laukhtina E., Glybochko P., Rapoport L., Herrmann T.R.W., Taratkin M. Comparative Analysis of Vaporization and Coagulation Properties of a Hybrid Laser (Combination of a Thulium and Blue Diode Laser) Vs Thulium and Ho:YAG Lasers: Potential Applications in Endoscopic Enucleation of the Prostate. J Endourol. 2020;34(8):862–867. doi: 10.1089/end.2020.0009. PMID: 3229204
- Pal R.P., Koupparis A..J. Expanding the indications of robotic surgery in urology: A systematic review of the literature. Arab J Urol. 2018;16(3):270–284. doi: 10.1016/j.aju.2018.05.005. PMID: 30147957; PMCID: PMC6105341
- Sergi F., Falavolti C., Bove A.M., Buscarini M. Robotic-assisted laparoscopic simple prostatectomy and bladder diverticulectomy with temporary clamping of internal iliac arteries. J Robot Surg. 2014;8(1):81–83. doi: 10.1007/s11701-012-0390-z. Epub 2013 Jan 10. PMID: 27637244.
- Vickman R.E., Franco O.E., Moline D.C., Vander Griend D.J., Thumbikat P., Hayward S.W. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review. Asian J Urol. 2020;7(3):191–202. doi: 10.1016/j.ajur.2019.10.003. Epub 2019 Oct 19. PMID: 32742923; PMCID: PMC7385520
Supplementary files
